| Takeda Pharma AG - Cuvitru 200 mg/ml, Injektionslösung |
| 65992 | | 01 | | Cuvitru 200 mg/ml | | Injektionslösung | | J06BA01 | | Immunglobuline, normal human, zur extravasalen Anwendung | | 14.10.2016 | | |
|
| Composition |
| Solvens (i.m.): immunoglobulinum humanum normale 200 mg, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Solvens (i.m.) | | | Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Immunoglobulinum Humanum Normale | 200 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Immunoglobulinum Humanum Normale | 10 g |
| | | | Agents auxilliaires |
|---|
| Glycine |
| |
|
|
